Top Stories

Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness


A woman receives an injection during phase 3 testing for the Johnson & Johnson vaccine candidate.

Johnson & Johnson via AP

Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing  “an unexplained illness in a study participant.”


Johnson & Johnson Covid-19 vaccine study paused due to unexplained illness in participant

Previous article

Coronavirus response can ‘reshape the future of energy,’ IEA says

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories